Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price was up 12.7% during trading on Monday . The stock traded as high as C$7.77 and last traded at C$7.65. Approximately 1,752,120 shares changed hands during trading, a decline of 16% from the average daily volume of 2,082,528 shares. The stock had previously closed at C$6.79.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group cut their price target on shares of Canopy Growth from C$5.00 to C$3.50 and set a "sell" rating for the company in a report on Monday, August 12th.
Get Our Latest Analysis on Canopy Growth
Canopy Growth Trading Up 12.8 %
The company's 50 day simple moving average is C$6.52 and its two-hundred day simple moving average is C$9.25. The stock has a market cap of C$650.03 million, a price-to-earnings ratio of -0.97, a price-to-earnings-growth ratio of -0.01 and a beta of 1.79. The company has a debt-to-equity ratio of 117.00, a quick ratio of 2.32 and a current ratio of 2.15.
Insider Buying and Selling at Canopy Growth
In other Canopy Growth news, Director David Eric Klein sold 40,135 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of C$8.35, for a total transaction of C$335,303.84. In related news, Senior Officer Christelle Gedeon sold 16,788 shares of the company's stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of C$8.35, for a total transaction of C$140,253.67. Also, Director David Eric Klein sold 40,135 shares of Canopy Growth stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of C$8.35, for a total transaction of C$335,303.84. Corporate insiders own 0.21% of the company's stock.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Further Reading
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
